Research to Practice (Neil Love) webcast- tonight

[karen z]

Not sure if the "click here" link below will work as I copied/pasted from an e-mail I received. If interested, you might call and provide organization with your e-mail address to register and get further instructions. Tonight's webcast appears to be on HER 2 cancer. E-mail I received:

As a company based in Miami, we want to be in front of the TV at tip-off time maybe even more than you do. Fortunately, that won’t be a problem as tonight’s 1-hour webcast from 7:30 PM to 8:30 PM ET will end in time for you to get ready to watch the Miami Heat try to close out the series against the Oklahoma City Thunder. Regardless of whether or not you are a basketball fan, if you want to stay on top of the many important developments in the management of HER2-positive breast cancer, don’t miss tonight’s event. For more information on this exciting educational activity, click here.


Go Heat!

Neil Love, MD
Research To Practice
Miami, Florida

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Research To Practice designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an educational grant from Genentech BioOncology.

Research To Practice
One Biscayne Tower
2 South Biscayne Boulevard, Suite 3600
Miami, FL 33131

[karen z]

(800) 233-6153 (appears to be a phone number you can use to register for tonight's webcast)
karen

[Rolepaul]

I will definitely want to watch this and will call them. Does this regard TDM-1, Herceptin, Pertuzumab, Avastin, or all the Genentech product lines? A lot of work in this over many years.